Please try another search
SinoMab BioScience Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of therapeutics for the treatment of immunological diseases primarily monoclonal antibody (mAb)-based biologics. Its flagship product is SM03, a first-in-target anti-CD22 mAb, which is in Phase III clinical trial for the treatment of rheumatoid arthritis (RA), as well as in various clinical stages for other immunological diseases, such as systemic lupus erythematosus (SLE), Sjogren’s syndrome (SS), and non-Hodgkin's lymphoma (NHL). The company also focuses on developing SN1011, a Bruton’s tyrosine kinase inhibitor, which is in Phase II clinical trial for the treatment of pemphigus, as well as in phase 1 clinical trial to treat multiple sclerosis, SLE, and NMOSD. Its products under the preclinical stage comprise SM17 for the treatment of asthma, atopic dermatitis, and idiopathic pulmonary fibrosis; SM06 to treat RA, SLE, NMOSD, and SS; SM09 for the treatment of NHL and RA; and TNF2 for the treatment of autoimmune diseases. It operates in Mainland China, the Cayman Islands, and Hong Kong. SinoMab BioScience Limited was incorporated in 2001 and is headquartered in Tai Po, Hong Kong.
Name | Age | Since | Title |
---|---|---|---|
Shui On Leung | 62 | 2001 | Founder, Chairman & CEO |
Dylan Carlo Tinker | 55 | 2019 | Independent Non-Executive Director |
Xun Dong | 49 | 2019 | Non-Executive Director |
Lei Shi | 38 | 2021 | Non-Executive Director |
Haigang Chen | 41 | 2017 | Non-Executive Director |
Wenyi Liu | 37 | 2017 | Non-Executive Director |
George William Hunter Cautherley | 81 | 2019 | Independent Non Executive Director |
Ping Cho Hon | 65 | 2019 | Independent Non-Executive Director |
Chi Ming Lee | 70 | 2021 | Independent Non-Executive Director |
Jianmin Zhang | 47 | 2023 | Non-Executive Director |
Shanchun Wang | 56 | 2022 | President of China & Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review